🇺🇸 FDA
Patent

US 7176201

Modulation of anxiety through blockade of anandamide hydrolysis

granted A61PA61P25/00A61P25/02

Quick answer

US patent 7176201 (Modulation of anxiety through blockade of anandamide hydrolysis) held by The Regents of the University of California expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
85
CPC classes
A61P, A61P25/00, A61P25/02, A61P25/04, A61P25/08